UK markets open in 3 hours 51 minutes

Lexicon Pharmaceuticals, Inc. (LXRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.6700-0.1000 (-5.65%)
At close: 04:00PM EDT
1.6701 +0.00 (+0.01%)
After hours: 07:55PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
2,310
1,204
139
298
23,995
-
Cost of revenue
116
85
0
0
1,929
-
Gross profit
2,194
1,119
139
298
22,066
-
Operating expenses
Research development
61,233
58,887
52,816
55,046
153,621
-
Selling general and administrative
126,902
113,982
48,083
32,342
47,230
-
Total operating expenses
188,135
172,869
100,899
87,388
200,851
-
Operating income or loss
-185,941
-171,750
-100,760
-87,090
-178,785
-
Interest expense
16,228
13,101
2,780
802
14,544
-
Total other income/expenses net
-
-
-
-
131,988
-28,638
Income before tax
-193,582
-177,119
-101,944
-87,758
-58,574
-
Income tax expense
-
-
-
0
0
-6,014
Income from continuing operations
-193,582
-177,119
-101,944
-87,758
-58,574
-
Net income
-193,582
-177,119
-101,944
-87,758
-58,574
-
Net income available to common shareholders
-193,582
-177,119
-101,944
-87,758
-58,574
-
Basic EPS
-0.62
-0.79
-0.62
-0.60
-0.53
-
Diluted EPS
-0.62
-0.79
-0.62
-0.60
-0.53
-
Basic average shares
165,733
221,130
165,733
145,652
110,841
-
Diluted average shares
165,733
221,130
165,733
145,652
110,841
-